Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2010-09

Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity

G. Chong, N.C. Tebbutt

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature

Jian-Ying Xu, Wen-Long Guan, Shi-Xun Lu [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2010

A Review of Docetaxel: Its Use in the Treatment of Gastric Cancer

Alessandro Inno, Michele Basso, Alessandra Cassano [...]

Clinical Medicine Insights: Therapeutics

Open access

Research article

First published 2026

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study

Wei-Ze Wong, Nai-Jung Chiang, Kuei-Chuan Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Long-term Survival,Tolerability,and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer

Youngbae Jeon, Sun Jin Sym, Bong Kyu Yoo [...]

Integrative Cancer Therapies

Open access

Research article

First published 2026

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

Keitaro Shimozaki, Akira Ooki, Kaoru Yoshikawa [...]

Therapeutic Advances in Gastroenterology

Search results

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy

Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity

Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature

A Review of Docetaxel: Its Use in the Treatment of Gastric Cancer

NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study

Long-term Survival,Tolerability,and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023